ConductScience.org, home

Paper34068720

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.

Kast RE and 2 others. Cells, 2021. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs. Papers, record 34068720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34068720

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.
PubMed
Journal
Cells
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2026-01-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kast RERichard Ehttps://orcid.org/0000-0002-7876-0400
2Halatsch MEMarc-Eric
3Rosell RRafael

Source PubMed

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcrylamidesMajor topic
Adenocarcinoma of LungMajor topic
Aniline CompoundsMajor topic
Chemotherapy, AdjuvantMajor topic
Drug RepositioningMajor topic
GlioblastomaMajor topic
Lung NeoplasmsMajor topic
Animals
Azithromycin
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Cyproheptadine
Drug Resistance, Neoplasm
ErbB Receptors
Humans
Loratadine
Mice
Neoplasm Metastasis
Pyrimethamine
Spironolactone
Indoles
Pyrimidines

Source PubMed

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,646,358Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients.Jpn J Clin Oncol2015https://conductscience.org/library/papers/25646358PubMed
231,688,928Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay.J Natl Cancer Inst2020https://conductscience.org/library/papers/31688928PubMed
324,682,826A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair.Nucleic Acids Res2014https://conductscience.org/library/papers/24682826PubMed
47,695,295Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7695295PubMed
529,970,185Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.Cancer Commun (Lond)2018https://conductscience.org/library/papers/29970185PubMed
632,414,008Spironolactone and XPB: An Old Drug with a New Molecular Target.Biomolecules2020https://conductscience.org/library/papers/32414008PubMed
728,369,077Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study.PLoS One2017https://conductscience.org/library/papers/28369077PubMed
828,710,746Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer.Target Oncol2017https://conductscience.org/library/papers/28710746PubMed
927,333,030Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment.EBioMedicine2016https://conductscience.org/library/papers/27333030PubMed
1026,404,748Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone.Int J Cardiol2015https://conductscience.org/library/papers/26404748PubMed
1125,886,177Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.BMC Cancer2015https://conductscience.org/library/papers/25886177PubMed
1230,501,602Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy.Curr Clin Pharmacol2019https://conductscience.org/library/papers/30501602PubMed
1325,211,298
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Oncotarget2014https://conductscience.org/library/papers/25211298PubMed
1427,435,396Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.Clin Cancer Res2016https://conductscience.org/library/papers/27435396PubMed
1531,590,360Acetylcholine Receptor Activation as a Modulator of Glioblastoma Invasion.Cells2019https://conductscience.org/library/papers/31590360PubMed
1630,257,958Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.Cancer Discov2018https://conductscience.org/library/papers/30257958PubMed
173,621,857Pyrimethamine in the myeloproliferative disorders: a forgotten treatment?Clin Lab Haematol1987https://conductscience.org/library/papers/3621857PubMed
1827,559,982
Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant case report.
Medicine (Baltimore)2016https://conductscience.org/library/papers/27559982PubMed
191,985,720A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.Cancer1991https://conductscience.org/library/papers/1985720PubMed
208,118,413The study of histamine H1- and H2-receptors in human lung cancer.Biochem Mol Biol Int1993https://conductscience.org/library/papers/8118413PubMed

See all 115 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
40,918,465Pyrimethamine Inhibits Human Ovarian Cancer by Triggering Lethal Mitophagy via Activating the p38/JNK/ERK Pathway.Oncol Res2025https://conductscience.org/library/papers/40918465PubMed
40,149,682UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer Treatment.Biomedicines2025https://conductscience.org/library/papers/40149682PubMed
39,796,688Synergistic Potential of Antibiotics with Cancer Treatments.Cancers (Basel)2024https://conductscience.org/library/papers/39796688PubMed
38,524,376
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone.
Oncoscience2024https://conductscience.org/library/papers/38524376PubMed
35,626,167MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.Cancers (Basel)2022https://conductscience.org/library/papers/35626167PubMed
35,456,023EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities.Cells2022https://conductscience.org/library/papers/35456023PubMed

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15,243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCG29,429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
AXL558PubTator's text mininghttps://conductscience.org/library/genes/558NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CDK41,019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
CDK61,021PubTator's text mininghttps://conductscience.org/library/genes/1021NCBI Gene
DCTN610,671PubTator's text mininghttps://conductscience.org/library/genes/10671NCBI Gene
DHFR1,719PubTator's text mininghttps://conductscience.org/library/genes/1719NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EIF4E1,977PubTator's text mininghttps://conductscience.org/library/genes/1977NCBI Gene
ERCC32,071PubTator's text mininghttps://conductscience.org/library/genes/2071NCBI Gene
H3P16644,914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
HTR1A3,350PubTator's text mininghttps://conductscience.org/library/genes/3350NCBI Gene
HTR2A3,356PubTator's text mininghttps://conductscience.org/library/genes/3356NCBI Gene
HTR2B3,357PubTator's text mininghttps://conductscience.org/library/genes/3357NCBI Gene
HTR2C3,358PubTator's text mininghttps://conductscience.org/library/genes/3358NCBI Gene
IGF1R3,480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene

See all 36 genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34068720

GET https://conductscience.org/api/papers/v1/34068720/references?page=2